Poll
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Pivotal trial of histotripsy system for kidney tumors reaches enrollment goal
Sintilimab plus fruquintinib under review in China for advanced renal cell carcinoma
Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC
Adjuvant pembrolizumab continues to show DFS, OS benefits for ccRCC at 5-year assessment
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Patient selection for cytoreductive nephrectomy in 2025